Core Viewpoint - Meili Tianyuan Medical Health (02373) announced the investment of idle funds into principal-protected financial products from Pudong Development Bank, totaling RMB 80 million [1] Group 1: Investment Details - The company’s non-wholly owned subsidiary, Beijing Beilish, subscribed to a principal-protected financial product from Pudong Development Bank for a total amount of RMB 80 million on February 13, 2026 [1] - Additionally, the company, through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, subscribed to several other principal-protected financial products from Pudong Development Bank, including RMB 70 million on November 21, 2025, RMB 10 million on November 28, 2025, and RMB 80 million on December 30, 2025 [1] - All the aforementioned financial products are still outstanding as of the date of the announcement [1]
美丽田园医疗健康(02373)附属认购总金额为8000万元的保本理财产品